Our round-up of recent biotech financings is headed by a $140 million Series D for GRIN Therapeutics, which also scored a $570 million licensing deal with Angelini Pharma. The New York-based biotech ...
Abstract: A gradient index (GRIN) metamaterial lens antenna with extremely high gain and high aperture efficiency is presented. The proposed antenna is much more advantageous in terms of gain and ...